Status:

UNKNOWN

The Assessment of Antimicrobial Peptides Against Fungal Infection

Lead Sponsor:

Assiut University

Conditions:

Fungal Infection

Eligibility:

All Genders

18-70 years

Brief Summary

* Identification of different types of fungi. * Determine sensitivity the profile and the resistance pattern of the clinical isolates against antifungal. * Determine the antifungal effects of defensin...

Detailed Description

Fungal infections are recurrent in the clinical environment and, annually, affect 25% of the general population worldwide, causing high morbidity and mortality rates. The indiscriminate use of broad-s...

Eligibility Criteria

Inclusion

  • \- Samples obtained from patients with cutaneous fungal infection and systemic fungal infection

Exclusion

  • Patients diagnosed to be viral or bacterial infections.
  • Patients on antibiotic or antifungal treatment

Key Trial Info

Start Date :

December 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05368948

Start Date

December 1 2022

End Date

June 1 2023

Last Update

May 10 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Assessment of Antimicrobial Peptides Against Fungal Infection | DecenTrialz